End-of-day quote
Other stock markets
|
||
- USD | - |
05-08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
05-08 | Sector Update: Health Care Stocks Slipping Wednesday Afternoon | MT |
Sales 2024 * | 60.23B 4,821B | Sales 2025 * | 62.55B 5,007B | Capitalization | 160B 12,814B |
---|---|---|---|---|---|
Net income 2024 * | 7.18B 575B | Net income 2025 * | 11.14B 892B | EV / Sales 2024 * | 3.61 x |
Net Debt 2024 * | 57.37B 4,592B | Net Debt 2025 * | 51.14B 4,094B | EV / Sales 2025 * | 3.38 x |
P/E ratio 2024 * |
20.2
x | P/E ratio 2025 * |
13.9
x | Employees | - |
Yield 2024 * |
5.89% | Yield 2025 * |
5.99% | Free-Float | 59.09% |
Latest transcript on Pfizer Inc
Managers | Title | Age | Since |
---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 62 | 31/12/92 |
David Denton
DFI | Director of Finance/CFO | 59 | 01/05/22 |
Jeff Settleman
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 31/03/20 | |
Ronald Blaylock
BRD | Director/Board Member | 64 | 22/02/17 |
Shantanu Narayen
BRD | Director/Board Member | 60 | 26/09/13 |
1st Jan change | Capi. | |
---|---|---|
+32.95% | 700B | |
+26.51% | 569B | |
-4.97% | 358B | |
+18.83% | 330B | |
+3.54% | 287B | |
+15.70% | 236B | |
+6.68% | 202B | |
-9.08% | 197B | |
+6.70% | 161B |